title: Anakinra in resistant gout: a case report.
abstract: Gout is a common cause of inflammatory arthritis. The classical treatment options in an acute gout attack are non-steroidal anti-inflammatory drugs, colchicine, and corticosteroids. Interleukin-1 inhibition has been shown to be an effective alternative when non-biologic therapies are ineffective or contraindicated. Herein, we report the case of a 69-year-old female who presented with polyarticular tophaceous gout treated successfully with anakinra.
authors.affiliation: a Department of Rheumatology , AZ Sint-Jan Brugge AV, Campus Sint-Jan , Brugge , Belgium.
authors.forename: Jana
authors.initials: J
authors.lastname: Van Wabeke
authors.affiliation: a Department of Rheumatology , AZ Sint-Jan Brugge AV, Campus Sint-Jan , Brugge , Belgium.
authors.forename: Eric
authors.initials: E
authors.lastname: Dhondt
authors.affiliation: a Department of Rheumatology , AZ Sint-Jan Brugge AV, Campus Sint-Jan , Brugge , Belgium.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Peene
authors.affiliation: a Department of Rheumatology , AZ Sint-Jan Brugge AV, Campus Sint-Jan , Brugge , Belgium.
authors.forename: Yves
authors.initials: Y
authors.lastname: Piette
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein
keywords: Anakinra; Gout; Interleukin-1 inhibitor